What emerged through such discussions was not optimism nor was it pessimism, but clarity. The consensus was striking in its consistency across sessions. JPM 2026 signalled genuine recovery – but not ...

In this podcast, Motley Fool analysts Karl Thiel, Tom King, and Tim Beyers discuss: Slow rolling chaos at the FDA and its effects on drug approvals. How to think about risk when investing in biotech.

The beauty industry has long harnessed biotechnology — namely taking the most powerful skincare ingredients in nature and recreating them using science to make them more potent, stable, ...

Get the latest federal technology news delivered to your inbox. The congressional working group on the national security ramifications of biotechnology is angling to publish and deliver new policy ...

BioTechAnalyzer is a research and analytics platform focused on making complex FDA-related biotechnology information clear, accessible, and actionable for investors. The platform focuses on late-stage ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

Recognition underscores ValGenesis’ pioneering leadership and continued innovation in digital validation and AI-enabled lifecycle management. ValGenesis, the market leader in enterprise validation ...

Forbes contributors publish independent expert analyses and insights. I write about finance, innovation, climate and sustainability Europe’s next wave of biotech innovation could determine how the ...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced it has been named “Overall Immunology Company of the Year” in ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

Slow rolling chaos at the FDA and its effects on drug approvals. How to think about risk when investing in biotech. A review of results from DNA researcher Twist Bioscience. Don't wait! Be sure to get ...